Ginkgo Bioworks: Difference between revisions
Content deleted Content added
Praxidicae (talk | contribs) Restored revision 1011944397 by TiagoLubiana (talk): Straight up spam |
Rambleraus (talk | contribs) merger |
||
| Line 21: | Line 21: | ||
}} |
}} |
||
'''Ginkgo Bioworks''' is a [[biotech company]] from the [[United States]] founded in 2009 by scientists from [[Massachusetts Institute of Technology|MIT]] and headed by [[Tom Knight (scientist)|Tom Knight]]. The company specializes in using [[genetic engineering]] to produce [[bacteria]] with industrial applications.<ref>{{cite news |last=Molteni|first=Megan|date=14 September 2017|title=With Designer Bacteria, Crops One Day Could Fertilize Themselves|url=https://www.wired.com/story/with-designer-bacteria-crops-could-one-day-fertilize-themselves/|work=[[Wired (magazine)|Wired]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Herper|first=Mathew|date=8 June 2016|title=Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry|url=https://www.forbes.com/sites/matthewherper/2016/06/08/boston-startup-raises-100-million-to-use-synthetic-biology-to-design-microbes-for-industry/#511b654f34c4|work=[[Forbes]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Adams|first=Susan|date=14 September 2017|title=Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer|url=https://www.forbes.com/sites/susanadams/2017/09/14/new-venture-aims-to-make-crops-produce-their-own-nitrogen-fertilizer/#5188255b1db0|work=[[Forbes]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Weisman|first=Robert|date=29 September 2016|title=Ginkgo Bioworks opens production site for custom cells|url=https://www.bostonglobe.com/business/2016/09/29/ginkgo-bioworks-opens-production-site-for-custom-cells/NOkYPicm7tIusnQRhp0TYL/story.html|work=[[Boston Globe]]|access-date=4 December 2017}}</ref> Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies.<ref name=":0">{{Cite news|url=https://www.reuters.com/article/us-ginkgobio-fundraising-idUSKBN1WO1U9|title=Ginkgo Bioworks raises $350 million fund for biotech spinouts|date=2019-10-09|work=Reuters|access-date=2019-11-07|language=en}}</ref> As of 2019, it was valued at $4.2 billion.<ref>{{Cite web|url=https://www.bloomberg.com/news/features/2019-11-06/ginkgo-bioworks-ceo-wants-biology-to-manufacture-physical-goods|title=Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods|website=[[Bloomberg News|Bloomberg]]|access-date=2019-11-07}}</ref> |
'''Ginkgo Bioworks''' is a [[biotech company]] from the [[United States]] founded in 2009 by scientists from [[Massachusetts Institute of Technology|MIT]] and headed by [[Tom Knight (scientist)|Tom Knight]]. The company specializes in using [[genetic engineering]] to produce [[bacteria]] with industrial applications.<ref>{{cite news |last=Molteni|first=Megan|date=14 September 2017|title=With Designer Bacteria, Crops One Day Could Fertilize Themselves|url=https://www.wired.com/story/with-designer-bacteria-crops-could-one-day-fertilize-themselves/|work=[[Wired (magazine)|Wired]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Herper|first=Mathew|date=8 June 2016|title=Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry|url=https://www.forbes.com/sites/matthewherper/2016/06/08/boston-startup-raises-100-million-to-use-synthetic-biology-to-design-microbes-for-industry/#511b654f34c4|work=[[Forbes]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Adams|first=Susan|date=14 September 2017|title=Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer|url=https://www.forbes.com/sites/susanadams/2017/09/14/new-venture-aims-to-make-crops-produce-their-own-nitrogen-fertilizer/#5188255b1db0|work=[[Forbes]]|access-date=4 December 2017}}</ref><ref>{{cite news |last=Weisman|first=Robert|date=29 September 2016|title=Ginkgo Bioworks opens production site for custom cells|url=https://www.bostonglobe.com/business/2016/09/29/ginkgo-bioworks-opens-production-site-for-custom-cells/NOkYPicm7tIusnQRhp0TYL/story.html|work=[[Boston Globe]]|access-date=4 December 2017}}</ref> Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies.<ref name=":0">{{Cite news|url=https://www.reuters.com/article/us-ginkgobio-fundraising-idUSKBN1WO1U9|title=Ginkgo Bioworks raises $350 million fund for biotech spinouts|date=2019-10-09|work=Reuters|access-date=2019-11-07|language=en}}</ref> As of 2019, it was valued at $4.2 billion.<ref>{{Cite web|url=https://www.bloomberg.com/news/features/2019-11-06/ginkgo-bioworks-ceo-wants-biology-to-manufacture-physical-goods|title=Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods|website=[[Bloomberg News|Bloomberg]]|access-date=2019-11-07}}</ref> |
||
On 11 May 2021, Gingko Bioworks announced plans of going public through a merger with [[Special-purpose acquisition company|SPAC]] Soaring Eagle at a $17.5 billion valuation.<ref>{{Cite news|last=Hussain|first=Niket Nishant, Noor Zainab|date=2021-05-11|title=Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 billion deal|language=en|work=Reuters|url=https://www.reuters.com/article/legal-us-gingkgo-m-a-soaring-eagle-idUSKBN2CS2CV|access-date=2021-05-12}}</ref> |
|||
== Funding == |
== Funding == |
||
Revision as of 09:57, 12 May 2021
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 2009 in Boston, Massachusetts, United States of America |
| Founders | Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton, Austin Che |
| Headquarters | , |
Key people | Tom Knight Jason Kelly Reshma Shetty Barry Canton Austin Che Christina Agapakis, Creative Director |
Number of employees | ~200 |
| Website | ginkgobioworks |
Ginkgo Bioworks is a biotech company from the United States founded in 2009 by scientists from MIT and headed by Tom Knight. The company specializes in using genetic engineering to produce bacteria with industrial applications.[1][2][3][4] Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies.[5] As of 2019, it was valued at $4.2 billion.[6]
On 11 May 2021, Gingko Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.[7]
Funding
In 2019, Ginkgo Bioworks received $290 million in September and a $350 million fund in October. [5]
References
- ^ Molteni, Megan (14 September 2017). "With Designer Bacteria, Crops One Day Could Fertilize Themselves". Wired. Retrieved 4 December 2017.
- ^ Herper, Mathew (8 June 2016). "Boston Startup Raises $100 Million To Use Synthetic Biology To Design Microbes For Industry". Forbes. Retrieved 4 December 2017.
- ^ Adams, Susan (14 September 2017). "Bayer And Ginkgo Bioworks, A Startup, Aim To Make Crops Produce Their Own Nitrogen Fertilizer". Forbes. Retrieved 4 December 2017.
- ^ Weisman, Robert (29 September 2016). "Ginkgo Bioworks opens production site for custom cells". Boston Globe. Retrieved 4 December 2017.
- ^ a b "Ginkgo Bioworks raises $350 million fund for biotech spinouts". Reuters. 2019-10-09. Retrieved 2019-11-07.
- ^ "Ginkgo Bioworks CEO Wants Biology to Manufacture Physical Goods". Bloomberg. Retrieved 2019-11-07.
- ^ Hussain, Niket Nishant, Noor Zainab (2021-05-11). "Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 billion deal". Reuters. Retrieved 2021-05-12.
{{cite news}}: CS1 maint: multiple names: authors list (link)
External links
 | This corporation or company article is a stub. You can help Wikipedia by expanding it. |